Press release
CAR-T Cell Therapy Market – A Revolution in Cancer Treatment Market Booming in 2019 and Predicted to Achieve Double Digit CAGR by 2028
CAR-T Cell Therapy Market
Lately, CAR T cell therapy has emerged as the new pillar for cancer treatment, creating high market potential for companies engaged in development and promotion of the product. Currently, Novartis International AG, Juno Therapeutics and Kite Pharma Inc. are dominating the CAR T cell therapy market. Clinical research by these players have revealed high rate of remission in patients with r/r B cell ALL and DLBCL. These companies are making major investments in R&D to expedite the clinical process. Novartis invested around US$ 9 billion in R&D – significant share of it is allocated towards oncology and development of CAR-T cell products in 2016. This novel cellular immunotherapy has attracted significant investment in last two years.
Get Exclusive Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/102
Top Key players-
- Novartis International AG
- Kite Pharma
- Juno Therapeutics
- Bluebird Bio
- Sorrento Therapeutics
- Mustang Bio
- Aurora Biopharma
- Legend Biotech
- Pfizer
- CARsgen Therapeutics
CAR-T cell therapy is expected to be an important development in cancer treatment and therapeutics industry due to its cost efficiency. Moreover, rising incidence of cancer is leading to high demand for its treatment. According to the World Cancer Research Fund International (WCRFI), around 14.1 million cancer cases were reported worldwide, in 2012. As per WCRFI, it is projected that by 2035, around 24 million cancer cases would be observed worldwide.
Moreover, introduction of new therapies into the market is further expected to bolster growth of CAR-T cell therapy market. For instance, in October 2017, the U.S. Food and Drug Administration granted marketing approval to Yescarta (axicabtagene ciloleucel), a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma. However, risks of side effects resulting in various neurological disorders is expected to hinder growth of the global CAR-T cell therapy market.
Ask Questions to Expertise @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/102
Detailed Segmentation:
Global CAR-T Cell Therapy Market, by Targeted Antigen:
CD 19
BCMA
HER2
GD2
CD 20
CD22
CD30
CD33
HER1
Others
Global CAR-T Cell Therapy Market, by Therapeutic Application:
Acute Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Diffuse Large B-cell Lymphoma (DLBCL)
Follicular Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Glioblastoma
Sarcoma
Neuroblastoma
Acute Myeloid Leukemia
Breast Cancer
Pancreatic Cancer
Hepatocellular Carcinoma
Colorectal Cancer
Others
Global CAR-T Cell Therapy Market, by Region:
North America
By Targeted Antigen:
CD 19
BCMA
HER2
GD2
CD 20
CD22
CD30
CD33
HER1
Others
By Therapeutic Application:
Acute Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Diffuse Large B-cell Lymphoma (DLBCL)
Follicular Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Glioblastoma
Sarcoma
Neuroblastoma
Acute Myeloid Leukemia
Breast Cancer
Pancreatic Cancer
Hepatocellular Carcinoma
Colorectal Cancer
Others
By Country:
U.S.
Canada
Latin America
By Targeted Antigen:
CD 19
BCMA
HER2
GD2
CD 20
CD22
CD30
CD33
HER1
Others
By Therapeutic Application:
Acute Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Diffuse Large B-cell Lymphoma (DLBCL)
Follicular Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Glioblastoma
Sarcoma
Neuroblastoma
Acute Myeloid Leukemia
Breast Cancer
Pancreatic Cancer
Hepatocellular Carcinoma
Colorectal Cancer
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Targeted Antigen:
CD 19
BCMA
HER2
GD2
CD 20
CD22
CD30
CD33
HER1
Others
By Therapeutic Application:
Acute Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Diffuse Large B-cell Lymphoma (DLBCL)
Follicular Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Glioblastoma
Sarcoma
Neuroblastoma
Acute Myeloid Leukemia
Breast Cancer
Pancreatic Cancer
Hepatocellular Carcinoma
Colorectal Cancer
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Targeted Antigen:
CD 19
BCMA
HER2
GD2
CD 20
CD22
CD30
CD33
HER1
Others
By Therapeutic Application:
Acute Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Diffuse Large B-cell Lymphoma (DLBCL)
Follicular Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Glioblastoma
Sarcoma
Neuroblastoma
Acute Myeloid Leukemia
Breast Cancer
Pancreatic Cancer
Hepatocellular Carcinoma
Colorectal Cancer
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Targeted Antigen:
CD 19
BCMA
HER2
GD2
CD 20
CD22
CD30
CD33
HER1
Others
By Therapeutic Application:
Acute Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Diffuse Large B-cell Lymphoma (DLBCL)
Follicular Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Glioblastoma
Sarcoma
Neuroblastoma
Acute Myeloid Leukemia
Breast Cancer
Pancreatic Cancer
Hepatocellular Carcinoma
Colorectal Cancer
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Targeted Antigen:
CD 19
BCMA
HER2
GD2
CD 20
CD22
CD30
CD33
HER1
Others
By Therapeutic Application:
Acute Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Diffuse Large B-cell Lymphoma (DLBCL)
Follicular Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Glioblastoma
Sarcoma
Neuroblastoma
Acute Myeloid Leukemia
Breast Cancer
Pancreatic Cancer
Hepatocellular Carcinoma
Colorectal Cancer
Others
By Country:
South Africa
Central Africa
North Africa
Get Discount @ https://www.coherentmarketinsights.com/insight/request-discount/102
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
1001 4th Ave,, #3200, Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CAR-T Cell Therapy Market – A Revolution in Cancer Treatment Market Booming in 2019 and Predicted to Achieve Double Digit CAGR by 2028 here
News-ID: 1504226 • Views: …
More Releases from Coherent Market Insights CMI
Single Shaft Turbine Market to Reach $3.78 Billion by 2030 Owing To Rapid Increa …
Coherent Market Insights published a report, titled, Single Shaft Turbine market was valued at US$ 2.63 Bn in 2023 and is expected to reach US$ 3.78 Bn by 2030, growing at a compound annual growth rate (CAGR) of 5.3% from 2023 to 2030. According to the report, the Global Single Shaft Turbine Market, By Type (Gas Turbines, Steam Turbines, Hydraulic Turbines, Wind Turbines, and Others), By Power Rating (Up to…
Nickel Metal Hydride Battery Market to Reach $4.01 Billion by 2030 Owing To Rapi …
Coherent Market Insights published a report, titled, global Nickel Metal Hydride Battery market was valued at US$ 2.93 Bn in 2023 and is expected to reach US$ 4.01 Bn by 2030, growing at a compound annual growth rate (CAGR) of 4.6% from 2023 to 2030. According to the report, the Global Nickel Metal Hydride Battery Market, By Product Type (Small-Sized Ni-MH Battery, Large-Sized Ni-MH Battery, Other), By Application (HEV, Retail…
Global Biodegradable Fabrics Market to Reach $13.44 Billion by 2031 Owing To Rap …
Coherent Market Insights published a report, titled, Global Biodegradable Fabrics market was valued at US$ 5.86 Bn in 2024 and is expected to reach US$ 13.44 Bn by 2031, growing at a compound annual growth rate (CAGR) of 12.6% from 2024 to 2031. Global Biodegradable Fabrics Market, By Product Type (Polyester, Polylactic Acid (PLA), Cellulose, Natural Fiber, Others), By Application (Textile, Furniture, Carpets, Others), By End Use Industry (Fashion, Medical,…
Global Circular Fashion Market to Reach $11 Billion by 2030 Owing to Offers Huge …
Coherent Market Insights published a report, titled, Global Circular Fashion Market was valued at US$ 6.09 Bn in 2023 and is expected to reach US$ 11 Bn by 2030, growing at a compound annual growth rate (CAGR) of 8.8% from 2023 to 2030. According to the report, the Global Circular Fashion Market, By Product Type (Apparel, Accessories, Footwear, Others), By End-use (Men, Women, Kids, Unisex, Others), By Distribution Channel (Online,…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview
Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports.
This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top…
